Dr. Carolina Villa is a bioprocess engineer with a doctorate in the field plus an MBA, and she spent over a decade in food and synbio, including commercialization and scale-up work at DSM, Planet B.io, and CJ Bio, before moving into venture investing at Nucleus Capital. She's known for handling technical diligence on biology deals, using techno-economic analysis to judge whether biotech companies can actually scale, and she's often called on to discuss the realities of industrial biomanufacturing and how founders should present technical risk to investors.